RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
153 hedge funds and large institutions have $1.25B invested in Revance Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 38 reducing their positions, and 13 closing their positions.
Holders
153
Holders Change
+9
Holders Change %
+6.25%
% of All Funds
3.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
64
Reduced
38
Closed
13
Calls
$6.79M
Puts
$10.5M
Net Calls
-$3.72M
Net Calls Change
-$8.08M
Top Buyers
1 |
1
BlackRock
New York
|
$123M |
2 |
PAI
2
Palo Alto Investors
Palo Alto,
California
|
$50.2M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$79.3M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$6.5M |
5 |
5
Wells Fargo
San Francisco,
California
|
$6.34M |